Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV001508939 | SCV001715380 | uncertain significance | not provided | 2019-05-21 | criteria provided, single submitter | clinical testing | |
John Atkinson Laboratory, |
RCV001849192 | SCV001905508 | uncertain significance | Thrombotic microangiopathy | 2015-06-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001508939 | SCV002173689 | uncertain significance | not provided | 2023-08-24 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 918 of the CFH protein (p.Gly918Glu). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Studies have shown that this missense change alters CFH gene expression (PMID: 34912830). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 1163680). This missense change has been observed in individual(s) with CFH-related conditions (PMID: 26283675, 34912830). This variant is present in population databases (no rsID available, gnomAD 0.003%). |
Genome- |
RCV003451774 | SCV004177348 | uncertain significance | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003451777 | SCV004177350 | uncertain significance | Age related macular degeneration 4 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003451776 | SCV004177351 | uncertain significance | Basal laminar drusen | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003451775 | SCV004177352 | uncertain significance | Factor H deficiency | 2023-04-11 | criteria provided, single submitter | clinical testing |